PINNACLE FINANCIAL PARTNERS INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PINNACLE FINANCIAL PARTNERS INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$45,990
-20.0%
1,0000.0%0.00%0.0%
Q2 2023$57,470
+53.3%
1,0000.0%0.00%0.0%
Q1 2023$37,500
+33.8%
1,0000.0%0.00%0.0%
Q4 2022$28,020
+0.1%
1,0000.0%0.00%0.0%
Q3 2022$28,000
-20.0%
1,0000.0%0.00%0.0%
Q2 2022$35,000
-2.8%
1,0000.0%0.00%0.0%
Q1 2022$36,000
+56.5%
1,0000.0%0.00%0.0%
Q4 2021$23,000
+21.1%
1,0000.0%0.00%0.0%
Q3 2021$19,000
-5.0%
1,0000.0%0.00%0.0%
Q2 2021$20,0000.0%1,0000.0%0.00%0.0%
Q1 2021$20,000
+5.3%
1,0000.0%0.00%0.0%
Q4 2020$19,0000.0%1,0000.0%0.00%0.0%
Q3 2020$19,000
-13.6%
1,0000.0%0.00%0.0%
Q2 2020$22,000
+46.7%
1,0000.0%0.00%0.0%
Q1 2020$15,000
-21.1%
1,0000.0%0.00%0.0%
Q4 2019$19,000
-5.0%
1,0000.0%0.00%
-50.0%
Q1 2019$20,000
+5.3%
1,0000.0%0.00%0.0%
Q3 2018$19,000
+26.7%
1,0000.0%0.00%
+100.0%
Q2 2018$15,000
-21.1%
1,0000.0%0.00%
-50.0%
Q1 2018$19,0001,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders